• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Anika Therapeutics Inc

+ Add to Watchlist


39.9300 USD 1.1100 2.70%

As of 20:10:00 ET on 09/15/2014.

Snapshot for Anika Therapeutics Inc (ANIK)

Open: 40.9700 Day's Range: 39.5000 - 40.9700 Volume: 247,296
Previous Close: 41.0400 52wk Range: 23.2600 - 52.4900 1-Yr Rtn: +66.44%

Stock Chart for ANIK

No chart data available.
  • ANIK:US 39.9300
  • 1D
  • 1M
  • 1Y
Interactive ANIK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANIK

Current P/E Ratio (ttm) 17.0772
Estimated P/E(12/2014) 16.9915
Relative P/E vs. SPX 0.9527
Earnings Per Share (USD) (ttm) 2.3382
Est. EPS (USD) (12/2014) 2.3500
Est. PEG Ratio 0.5664
Market Cap (M USD) 578.45
Shares Outstanding (M) 14.49
30 Day Average Volume 260,092
Price/Book (mrq) 3.6386
Price/Sale (ttm) 5.7642
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANIK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ANIK

Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products and devices. The Company's products, based on hyaluronic acid, promote the repair, protection, and healing of bone, cartilage, and soft tissue. Anika's products include ORTHOVISC and HYVISC which treat osteoarthritis.

Charles H SherwoodPresident/CEOSylvia CheungCFO/Treasurer/Secretary
Carol A BarnettChief Commercial OfficerJohn W Sheets JrChief Scientific Officer
More Company Profile & Key Executives for ANIK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil